当前位置 : 首页 > 市场合作 > 项目信息市场合作
Market cooperation| 发包方名称 | National Hospital Organization - Fukui |
| 发包方国别(国家/地区) | 日本 |
| 发包方座机 | |
| 发包方传真 | |
| 发包方邮箱 | |
| 发包方地址 | Director, Accounting Division, National Hospital Organization Awara National Hospital, 238-1 Kitagata, Awara-shi, Fukui-ken 910-4272, Japan |
| 发包方网址 | |
| 发包方联系人姓名 | Masato Nakashima |
| 发包方联系人座机 | 0776-79-1212 ext. 211 |
| 发包方联系人手机 | |
| 发包方联系人邮箱 | |
| 项目名称 | ①ADYNOVATE Intravenous Kit 3000 (3000 International Units, With solution×1 kit/case) 98 cases,②Alprolix Intravenous 3000 (3000 International Units, With solution×1 vial/case) 38 cases,③DARZQURO Combination Subcutaneous Injection 15㎖ (15㎖×1 vial/case) 48 c |
| 项目类型 | 其他 - 其他 |
| 项目预算¥ | |
| 项目投标截止时间 | 2021-09-22 |
| 项目开始时间 | |
| 项目结束时间 | |
| 服务商资质要求 | |
| 要求高匹配度成功案例个数 | |
| 项目交付地点 | |
| 是否准许转包或分包 | |
| 项目信息详述 |
⑴ Official in charge of disbursement of the procuring entity : Hiroshi Tsutani, Director, National Hospital Organization Awara National Hospital
⑵ Classification of the products to be procured : 4
⑶ Nature and quantity of the products to be purchased :
① ADYNOVATE Intravenous Kit 3000 (3000 International Units, With solution×1 kit/case) 98 cases
② Alprolix Intravenous 3000 (3000 International Units, With solution×1 vial/case) 38 cases
③ DARZQURO Combination Subcutaneous Injection 15㎖ (15㎖×1 vial/case) 48 cases
④ Pomalyst Capsules 2mg (2mg×PTP 7 capsule/case) 89 cases
⑷ Delivery period : From October 1, 2021 to September 30, 2022
⑸ Delivery place : National Hospital Organization Awara National Hospital
⑹ Qualification for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :
A not come under Article 5 of the Regulation concerning Contract for National Hospital Organization (NHO). Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause ;
B not come under Article 6 of the Regulation concerning Contract for NHO ;
C have Grade A, B or C in "Sales of products" for participating in tenders by Ministry of Health, Labour and Welfare (Single qualification for every ministry and agency) in Tokai-Hokuriku Region ;
D prove to have obtained the firstclass-license for selling drugs in accordance with the Phamaceutical Affairs Law ;
E prove that they can deliver the drugs on the date and to the place specified by the Obligating Officer ;
F meet the qualification requirements which the Obligating Officer may specify in accordance with Article 4 of the Regulation ;
⑺ Time-limit for tender : 3 : 00 P.M. September 22, 2021
⑻ Contact point for the notice : Masato Nakashima, Director, Accounting Division, National Hospital Organization Awara National Hospital, 238-1 Kitagata, Awara-shi, Fukui-ken 910-4272, Japan. TEL 0776-79-1212 ext. 211
|
版权所有:天津市数字贸易综合服务平台 备案号:津B2-20080229-9